Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures (PREV-URG)
Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures: A Multicenter, Randomized Controlled Exploratory Trial
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.
Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.
Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.
The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
Visão geral do estudo
Status
Condições
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Christelle JADEAU
- Número de telefone: +332 44 71 07 81
- E-mail: cjadeau@ch-lemans.fr
Estude backup de contato
- Nome: Cyrielle HOUALARD, MD
- Número de telefone: +332 43 43 43 43
- E-mail: choualard@ch-lemans.fr
Locais de estudo
-
-
Sarthe
-
La Flèche, Sarthe, França, 72205
- Pôle Santé Sarthe et Loir
-
Contato:
- Cyrielle HOUALARD, MD
- Número de telefone: +332 44 71 30 00
- E-mail: choualard@ch-lemans.fr
-
Le Mans, Sarthe, França, 72000
- Centre Hospitalier du Mans
-
Contato:
- Cyrielle HOUALARD, MD
- Número de telefone: +332 43 43 43 43
- E-mail: choualard@ch-lemans.fr
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Adult patients (≥ 18 years of age)
- Patients seen in the emergency departments of Le Mans University Hospital and the PSSL
- Patients who have given their free and informed oral consent
Exclusion Criteria:
- Patients who have previously participated in the study
- Patients with limited understanding of the French language
- Patients unable to give informed consent
- Individuals not enrolled in or not eligible for a social security program
- Individuals deprived of their liberty by judicial or administrative order
- Individuals receiving involuntary psychiatric care
- Individuals subject to a legal protective measure
- Pregnant or breastfeeding patients.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: A - Intervention
The first "intervention" group, designated A, is exposed to personalized information via a digital educational tool based on the characteristics entered for them.
|
The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.
|
|
Experimental: B - Control
The second "control" group, designated B, receives non-personalized information.
Using the same digital tool, the patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
The intervention involves providing non-personalized preventive health information.
The patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
proportion of patients who adhered to at least 25% of the preventive measures
Prazo: 6-8 weeks after the intervention.
|
The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term |
6-8 weeks after the intervention.
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
The proportion of patients who adhered to each of the preventive measures studied.
Prazo: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.
Prazo: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).
Prazo: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- CHM-2025/S02/17
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .